Neurotype Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 6

Neurotype General Information

Description

Developer of an electroencephalography-based neurotechnology platform designed to support recovery from substance use disorders by measuring brain responses associated with craving. The company's platform offers non-invasive electroencephalography, visual event-related potential analysis, clinical decision support reports, and closed-loop neurofeedback, enabling clinicians and treatment specialists to measure craving-related neural activity and guide targeted interventions for sustained recovery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4610 East Lake Street
  • Suite 306
  • Minneapolis, MN 55406-2364
  • United States
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Therapeutic Devices
Vertical(s)
Corporate Office
  • 4610 East Lake Street
  • Suite 306
  • Minneapolis, MN 55406-2364
  • United States

Neurotype Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotype Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Seed Round 16-Mar-2026 Completed Generating Revenue
11. Grant 01-Oct-2023 Completed Generating Revenue
10. Grant 01-Jul-2023 Completed Generating Revenue
9. Grant 19-Oct-2022 Completed Generating Revenue
8. Grant 10-Oct-2022 Completed Generating Revenue
7. Grant 28-Feb-2022 Completed Generating Revenue
6. Accelerator/Incubator 15-Apr-2021 Completed Generating Revenue
5. Grant 15-Sep-2020 Completed Generating Revenue
4. Grant 15-Jul-2020 $29.7K $405K Completed Startup
3. Accelerator/Incubator 01-Jan-2020 $405K $405K Completed Startup
To view Neurotype’s complete valuation and funding history, request access »

Neurotype Patents

Neurotype Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12343157-B2 Assessing motivated attention with cue reactivity Active 14-Apr-2020
US-20210315508-A1 Assessing motivated attention with cue reactivity Active 14-Apr-2020
US-20250311961-A1 Assessing motivated attention with cue reactivity Pending 14-Apr-2020 A61B5/378

Neurotype Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurotype Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Frontline Ventures Venture Capital Minority
Techstars Accelerator/Incubator Minority
Minnesota Department of Employment and Economic Development Government
National Institutes of Health Government
National Institute on Drug Abuse (NIDA) Government
You’re viewing 5 of 6 investors. Get the full list »

Neurotype FAQs

  • When was Neurotype founded?

    Neurotype was founded in 2019.

  • Where is Neurotype headquartered?

    Neurotype is headquartered in Minneapolis, MN.

  • What is the size of Neurotype?

    Neurotype has 2 total employees.

  • What industry is Neurotype in?

    Neurotype’s primary industry is Monitoring Equipment.

  • Is Neurotype a private or public company?

    Neurotype is a Private company.

  • What is Neurotype’s current revenue?

    The current revenue for Neurotype is .

  • How much funding has Neurotype raised over time?

    Neurotype has raised $460K.

  • Who are Neurotype’s investors?

    Frontline Ventures, Techstars, Minnesota Department of Employment and Economic Development, National Institutes of Health, and National Institute on Drug Abuse (NIDA) are 5 of 6 investors who have invested in Neurotype.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process